Compare KNTK & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KNTK | AMRX |
|---|---|---|
| Founded | 2017 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.0B |
| IPO Year | 2017 | 2018 |
| Metric | KNTK | AMRX |
|---|---|---|
| Price | $46.13 | $16.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 5 |
| Target Price | ★ $48.58 | $15.60 |
| AVG Volume (30 Days) | 828.1K | ★ 1.8M |
| Earning Date | 05-06-2026 | 05-01-2026 |
| Dividend Yield | ★ 6.53% | N/A |
| EPS Growth | 157.84 | ★ 157.89 |
| EPS | N/A | ★ 0.19 |
| Revenue | ★ $160,617,000.00 | N/A |
| Revenue This Year | $7.80 | $4.48 |
| Revenue Next Year | $13.93 | $7.13 |
| P/E Ratio | ★ N/A | $84.29 |
| Revenue Growth | ★ 8.23 | N/A |
| 52 Week Low | $31.33 | $7.67 |
| 52 Week High | $51.51 | $16.61 |
| Indicator | KNTK | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 47.25 | 78.56 |
| Support Level | $44.39 | $12.46 |
| Resistance Level | $46.88 | N/A |
| Average True Range (ATR) | 1.25 | 0.57 |
| MACD | -0.00 | 0.27 |
| Stochastic Oscillator | 53.49 | 90.29 |
Kinetik Holdings Inc is a midstream operator that provides comprehensive gathering, transportation, compression, processing and treating services. Its activities also include NGL stabilization and transportation, produced water gathering and disposal, and crude oil gathering, stabilization, storage, and transportation. The company operates in two reportable segments: i) The Midstream Logistics segment operates under three service offerings: 1) gas gathering and processing, 2) crude oil gathering, stabilization, and storage services, and 3) produced water gathering and disposal. ii) The Pipeline Transportation segment consists of two EMI Pipelines originating in the Permian Basin with various access points to the U.S. Gulf Coast, Kinetik NGL Pipelines, and Delaware Link Pipeline.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.